Ingrid Maes (°1966) has 20 years’ experience in the pharma, biotech and life sciences industry and before joining PwC she had several positions at high-tech multinational technology and engineering companies, involved with strategy, innovation and new technology development, and managed worldwide innovative projects in the pharma and life sciences R&D and manufacturing area. Now she is Director at PwC Advisory and responsible for the pharma & life sciences sector for Belgium and business development for the EMEA region. Her key activity areas are: R&D and manufacturing, innovation & technology management, strategy and regulatory compliance.

The new science of personalised medicine:

translating the promise into practice

Her presentation highlights the main elements of a future vision on the

merged pharma, biotech and healthcare landscape. New opportunities are

emerging around the development of personalised medicine, supported by

translational research and diagnostics, creating a booming market.